Results 31 to 40 of about 19,172 (198)

Emerging Nanotechnology Strategies for Obesity Therapy

open access: yesAdvanced Science, EarlyView.
Three types of nanomaterials used for obesity treatment are highlighted, including inorganic nanomaterials, organic nanomaterials and biomimetic nanomaterials. A detailed and comprehensive introduction to the recent nanotechnology strategies for obesity management is also provided, including drug delivery, photodynamic therapy, hyperthermia, gas ...
Weili Chang   +5 more
wiley   +1 more source

Liver Transplantation for Budd-Chiari Syndrome [PDF]

open access: yes, 1976
Orthotopic liver transplantation was accomplished in a 22-year-old woman dying of the Budd-Chiari syndrome. She is well and has normal liver function 16 months postoperatively.
Porter, KA   +4 more
core   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio   +10 more
wiley   +1 more source

Hemodynamic Evaluation of Nonselective \u3b2-Blockers in Patients with Cirrhosis and Refractory Ascites [PDF]

open access: yes, 2018
BACKGROUND:Nonselective \u3b2-blockers (NSBB) have been associated with increased incidence of paracentesis-induced circulatory dysfunction (PICD) and reduced survival in patients with cirrhosis and refractory ascites.
Angeli, Paolo   +10 more
core   +2 more sources

Beta-blokers in patients with cirrhosis and infection: don't blame too soon. [PDF]

open access: yes, 2015
We found that PPI-users had a higher rate and BBs-users a lower rate of infections. The lower infection rate and better prognosis of BB-users can not be attributed, as suggested by Schiavon et al., to a higher proportion of variceal bleeding in this ...
LUCIDI, CRISTINA   +3 more
core   +1 more source

The role of rehabilitation across the continuum of liver disease from cirrhosis to transplantation and beyond: A narrative review

open access: yesPM&R, EarlyView.
Abstract Objective The authors' objective with this narrative review is to explore the impact of rehabilitative interventions at each stage of liver disease. Type Narrative review. Literature Survey Literature search conducted in Medline, Embase, and Google Scholar databases.
Laura Malmut   +5 more
wiley   +1 more source

Nephrogenic systemic fibrosis risk and liver disease. [PDF]

open access: yes, 2014
Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis,
Chow, Daniel S   +6 more
core   +3 more sources

Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites [PDF]

open access: yes, 2019
Background: bioelectrical impedance analysis is a technique for the determination of the hydropic component. The hydropic component, determined by blood volume, could be a reflection of the hemodynamic situation.
Ampuero Herrojo, Javier   +4 more
core   +5 more sources

Effects of Shunt Position on the Prognosis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhotic Esophagogastric Variceal Bleeding

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
The challenge of transjugular intrahepatic portosystemic shunt (TIPS) remains the puncture of the portal vein. Establishing an optimal shunt position in the left branch of the portal vein would be a better option for reducing the risk of postoperative hepatic encephalopathy and stent dysfunction.
Yi‐Han Yang   +6 more
wiley   +1 more source

Orthotopic liver transplantation for fulminant and subacute hepatic failure [PDF]

open access: yes, 1988
Fulminant and subacute hepatitis are conditions characterized by rapid liver failure, which can lead to death in 80 to more than 95% of the cases with medical supportive care only.
Iwatsuki, S, Starzl, TE, Stieber, AC
core  

Home - About - Disclaimer - Privacy